The ground-breaking prognostic test that can predict the onset of diabetic kidney disease and future kidney function decline in patients with type 2 diabetes.
Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease worldwide¹. Most people with diabetic kidney disease do not have symptoms². Prevention is better than cure – transform clinical outcomes.
16th June 2022 - Pilot test kit takes Proteomics step closer to sales – The West Australian
16th June 2022 - Proteomics International Laboratories (ASX:PIQ) completes PromarkerD manufacturing tech transfer – The Market Herald
16th June 2022 - PromarkerD manufacturing tech-transfer completed – Successful production of components for over 50,000 tests
6th June 2022 - Study boosts diagnostic potential for Proteomics – The West Australian
“PromarkerD will save lives and healthcare costs” – Dr Richard Lipscombe to American Diabetes Association (ADA) TV